Cargando…
Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682865/ https://www.ncbi.nlm.nih.gov/pubmed/36435338 http://dx.doi.org/10.1016/j.radonc.2022.11.009 |
_version_ | 1784834950624706560 |
---|---|
author | Li, Zheng Hu, Yue Li, Qiang |
author_facet | Li, Zheng Hu, Yue Li, Qiang |
author_sort | Li, Zheng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9682865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96828652022-11-23 Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” Li, Zheng Hu, Yue Li, Qiang Radiother Oncol Letter to the Editor Elsevier B.V. 2023-01 2022-11-23 /pmc/articles/PMC9682865/ /pubmed/36435338 http://dx.doi.org/10.1016/j.radonc.2022.11.009 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Li, Zheng Hu, Yue Li, Qiang Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” |
title | Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” |
title_full | Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” |
title_fullStr | Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” |
title_full_unstemmed | Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” |
title_short | Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial” |
title_sort | letter regarding “the clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe covid-19 pneumonia: rtmx-20 trial” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682865/ https://www.ncbi.nlm.nih.gov/pubmed/36435338 http://dx.doi.org/10.1016/j.radonc.2022.11.009 |
work_keys_str_mv | AT lizheng letterregardingtheclinicalefficacyoflowdosewholelungirradiationinmoderatetoseverecovid19pneumoniartmx20trial AT huyue letterregardingtheclinicalefficacyoflowdosewholelungirradiationinmoderatetoseverecovid19pneumoniartmx20trial AT liqiang letterregardingtheclinicalefficacyoflowdosewholelungirradiationinmoderatetoseverecovid19pneumoniartmx20trial |